000 | 01573 a2200469 4500 | ||
---|---|---|---|
005 | 20250517233029.0 | ||
264 | 0 | _c20191115 | |
008 | 201911s 0 0 eng d | ||
022 | _a1879-0593 | ||
024 | 7 |
_a10.1016/j.oraloncology.2018.07.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Michelle M | |
245 | 0 | 0 |
_aSurvival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age. _h[electronic resource] |
260 |
_bOral oncology _c09 2018 |
||
300 |
_a71-75 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aChemoradiotherapy, Adjuvant |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xmortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aOropharyngeal Neoplasms _xmortality |
650 | 0 | 4 | _aPapillomavirus Infections |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 | _aPropensity Score |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aSquamous Cell Carcinoma of Head and Neck _xmortality |
700 | 1 | _aColevas, A Dimitrios | |
700 | 1 | _aMegwalu, Uchechukwu | |
700 | 1 | _aDivi, Vasu | |
773 | 0 |
_tOral oncology _gvol. 84 _gp. 71-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.oraloncology.2018.07.012 _zAvailable from publisher's website |
999 |
_c28737544 _d28737544 |